Cargando…
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes
Oxidative stress contributes to pathology associated with inflammatory brain disorders and therapies that upregulate antioxidant pathways may be neuroprotective in diseases such as multiple sclerosis. Dimethyl fumarate, a small molecule therapeutic for multiple sclerosis, activates cellular antioxid...
Autores principales: | Huang, He, Taraboletti, Alexandra, Shriver, Leah P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427661/ https://www.ncbi.nlm.nih.gov/pubmed/25967672 http://dx.doi.org/10.1016/j.redox.2015.04.011 |
Ejemplares similares
-
Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis
por: Guerriero, Claudia, et al.
Publicado: (2022) -
Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease
por: Warabi, Yoko, et al.
Publicado: (2019) -
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
por: Bhargava, Pavan, et al.
Publicado: (2018) -
Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
por: Chen, Kaiyuan, et al.
Publicado: (2021) -
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity
por: Liebmann, Marie, et al.
Publicado: (2021)